Fresh off filing a lawsuit alleging that a pharmacy benefit manager overcharged his state, Ohio’s attorney general is now proposing a series of legislative reforms that would toughen oversight of these controversial middlemen.

The move by Attorney General Dave Yost comes amid escalating concern among Ohio officials over the prescription drug contracts administered by PBMs on behalf of the state Medicaid program and other agencies. In doing so, Yost appears to be suggesting a blueprint for other states that are grappling with rising drug costs and starting to scrutinize PBM business practices as one possible way to alleviate the financial strain.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Mazel Tov !!!!! Let’s hope this does become law. Every state should follow
    Ohio’s footsteps regarding PBM’s. That was big of PCMA to applaud the Ohio
    AG. I guess they don’t look good in orange !!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy